Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 16 07 2020
accepted: 01 06 2021
entrez: 9 7 2021
pubmed: 10 7 2021
medline: 29 10 2021
Statut: epublish

Résumé

Alzheimer's disease (AD), non-AD dementia, and Parkinson's disease (PD) are increasingly common in older adults, yet all risk factors for their onset are not fully understood. Consequently, environmental exposures, including air pollution, have been hypothesized to contribute to the etiology of neurodegeneration. Because persistently elevated rates of AD mortality in the southern Piedmont area of North Carolina (NC) have been documented, we studied mortality and hospital admissions for AD, non-AD dementia, and PD in residential populations aged 65+ with long-term exposures to elevated levels of ambient air particulate matter 2.5 (PM2.5) exceeding the World Health Organization (WHO) air quality standards (≥10μg/m3). Health data were obtained from the State Center for Health Statistics and the Healthcare Cost and Utilization Project. PM2.5 levels were obtained from the MODIS/MISR and SeaWiFS datafiles. Residents in the Study group of elevated air particulate matter (87 zip codes with PM2.5≥10μg/m3) were compared to the residents in the Control group with low levels of air particulate matter (81 zip codes with PM2.5≤7.61μg/m3), and were found to have higher age-adjusted rates of mortality and hospital admissions for AD, non-AD dementia, and PD, including a most pronounced increase in AD mortality (323/100,000 vs. 257/100,000, respectively). After adjustment for multiple co-factors, the risk of death (odds ratio, or OR) from AD in the Study group (OR = 1.35, 95%CI[1.24-1.48]) was significantly higher than ORs of non-AD dementia or PD (OR = 0.97, 95%CI[0.90-1.04] and OR = 1.13, 95%CI[0.92-1.31]). The OR of hospital admissions was significantly increased only for AD as a primary case of hospitalization (OR = 1.54, 95%CI[1.31-1.82]). Conclusion: NC residents aged 65+ with long-term exposures to ambient PM2.5 levels exceeding the WHO standard had significantly increased risks of death and hospital admissions for AD. The effects for non-AD dementia and PD were less pronounced.

Identifiants

pubmed: 34242242
doi: 10.1371/journal.pone.0253253
pii: PONE-D-20-22098
pmc: PMC8270415
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0253253

Subventions

Organisme : NIA NIH HHS
ID : R01 AG057801
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066133
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exist.

Références

JAMA. 2002 Mar 6;287(9):1132-41
pubmed: 11879110
Environ Res. 2018 Oct;166:348-362
pubmed: 29935448
Neuroepidemiology. 2006;26(1):16-22
pubmed: 16254449
Neurotoxicology. 2008 May;29(3):479-88
pubmed: 18289684
Sci Rep. 2018 Apr 9;8(1):5708
pubmed: 29632393
Int J Chron Obstruct Pulmon Dis. 2014 Jun 16;9:613-27
pubmed: 25018627
Int J Environ Res Public Health. 2018 Nov 07;15(11):
pubmed: 30405070
Neurotoxicology. 2012 Oct;33(5):972-84
pubmed: 22981845
J Alzheimers Dis. 2018;61(1):67-78
pubmed: 29103040
Med Sci Monit. 2018 Aug 25;24:5925-5934
pubmed: 30144390
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
Environ Health Perspect. 2016 Nov;124(11):1759-1765
pubmed: 27285422
Environ Health Perspect. 2005 Aug;113(8):1032-8
pubmed: 16079075
J Alzheimers Dis. 2019;70(s1):S145-S163
pubmed: 30775976
Am J Community Psychol. 2013 Mar;51(1-2):140-50
pubmed: 22886284
Ecotoxicol Environ Saf. 2012 Apr;78:327-35
pubmed: 22177483
Parkinsonism Relat Disord. 2019 Mar;60:57-63
pubmed: 30297212
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Toxicol Pathol. 2004 Nov-Dec;32(6):650-8
pubmed: 15513908
Am J Epidemiol. 2010 Dec 15;172(12):1357-63
pubmed: 20959505
PLoS One. 2014 Aug 12;9(8):e103078
pubmed: 25115939
Arch Intern Med. 2012 Feb 13;172(3):219-27
pubmed: 22332151
Am J Epidemiol. 2012 May 1;175(9):898-906
pubmed: 22491084
J Alzheimers Dis. 2015;43(3):1039-58
pubmed: 25147109
Environ Res. 2009 Nov;109(8):1004-11
pubmed: 19733348
Environ Health Perspect. 2011 May;119(5):682-7
pubmed: 21172758
J Alzheimers Dis. 2015;50(1):71-6
pubmed: 26639973
J Am Geriatr Soc. 2011 Oct;59(10):1823-8
pubmed: 22091495
J Environ Public Health. 2012;2012:472751
pubmed: 22523504
J Neuropsychiatry Clin Neurosci. 2008 Fall;20(4):501
pubmed: 19196946
Neurotoxicology. 2017 Mar;59:140-154
pubmed: 26721665
MMWR Morb Mortal Wkly Rep. 2017 May 26;66(20):521-526
pubmed: 28542120
Lancet. 2018 Feb 3;391(10119):462-512
pubmed: 29056410
FASEB J. 2004 Oct;18(13):1618-20
pubmed: 15319363
Environ Health Perspect. 2011 Apr;119(4):455-60
pubmed: 21172759
J Gerontol B Psychol Sci Soc Sci. 2015 Mar;70(2):322-8
pubmed: 24906394
Isr J Health Policy Res. 2016 Nov 15;5:51
pubmed: 27879970
JAMA. 2000 Mar 22-29;283(12):1571-7
pubmed: 10735393
J Occup Environ Med. 2015 May;57(5):509-17
pubmed: 25951420
Alzheimers Dement (Amst). 2015 May 14;1(2):220-8
pubmed: 27239507
Hum Biol. 1966 Sep;38(3):309-17
pubmed: 5977534
Environ Int. 2020 Mar;136:105510
pubmed: 32004873
Environ Health Perspect. 2017 Aug 18;125(8):087011
pubmed: 28886605
Sci Total Environ. 2019 Mar 10;655:1240-1248
pubmed: 30577116
Environ Res. 2019 Jan;168:448-459
pubmed: 30391837
Environ Health Perspect. 2016 Mar;124(3):306-12
pubmed: 26305859
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
J Expo Sci Environ Epidemiol. 2014 Jul;24(4):365-71
pubmed: 24496220
Am J Clin Nutr. 2006 Jan;83(1):139-45
pubmed: 16400062
Lancet. 2017 Feb 18;389(10070):718-726
pubmed: 28063597
J Appl Toxicol. 2017 Jun;37(6):644-667
pubmed: 28299803
J Alzheimers Dis. 2015;44(2):573-84
pubmed: 25310992
Environ Int. 2017 Nov;108:271-277
pubmed: 28917207
Stroke. 2015 May;46(5):1161-6
pubmed: 25908455
Environ Sci Technol. 2016 Apr 5;50(7):3762-72
pubmed: 26953851
Neurotoxicology. 2005 Jan;26(1):133-40
pubmed: 15527881
Neurotoxicology. 2014 Jul;43:3-9
pubmed: 24012887
Environ Int. 2016 Nov;96:75-81
pubmed: 27614945
J Clin Epidemiol. 1998 Jul;51(7):587-95
pubmed: 9674666
Environ Health Perspect. 2016 Jan;124(1):23-9
pubmed: 25978701
Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58
pubmed: 21626386
Transl Psychiatry. 2017 Jan 31;7(1):e1022
pubmed: 28140404
Biomed J. 2018 Jun;41(3):141-162
pubmed: 30080655
Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):311-6
pubmed: 20473132
J Am Geriatr Soc. 2012 Nov;60(11):2075-80
pubmed: 23126566
Neurotoxicology. 2009 Mar;30(2):231-9
pubmed: 19150462
Environ Health Perspect. 2016 Mar;124(3):351-6
pubmed: 26151951
Toxicol In Vitro. 2002 Jun;16(3):209-18
pubmed: 12020593
Int J Neurosci. 2015;125(10):717-25
pubmed: 25364880
Environ Health Perspect. 2014 Sep;122(9):933-8
pubmed: 24905870
Brain. 2019 Jan 1;143(1):289-302
pubmed: 31746986
Hum Exp Toxicol. 2011 Jul;30(7):579-90
pubmed: 20554636
Neurology. 2001 Jan 9;56(1):49-56
pubmed: 11148235
Science. 2017 Jan 27;355(6323):342-345
pubmed: 28126768
NCHS Data Brief. 2013 Mar;(116):1-8
pubmed: 23742787
PLoS One. 2016 Feb 05;11(2):e0147632
pubmed: 26849365
Neurotoxicology. 2016 Sep;56:235-253
pubmed: 27328897
Toxicol Pathol. 2008 Feb;36(2):289-310
pubmed: 18349428
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804
Environ Health. 2014 Oct 07;13:80
pubmed: 25294559
Int J Hyg Environ Health. 2015 Jan;218(1):1-11
pubmed: 25242804
J Alzheimers Dis. 2017;59(1):189-208
pubmed: 28598844
Environ Res. 2016 Nov;151:713-720
pubmed: 27640071
Environ Health. 2014 May 22;13(1):38
pubmed: 24886318
N Engl J Med. 2007 Feb 1;356(5):447-58
pubmed: 17267905
Sci Total Environ. 2017 Aug 15;592:451-457
pubmed: 28342386
Inhal Toxicol. 2015;27(10):462-7
pubmed: 26327340
Biomed Res Int. 2013;2013:161687
pubmed: 23509683
Alzheimers Dement. 2019 Jan;15(1):17-24
pubmed: 30243772

Auteurs

Sung Han Rhew (SH)

Memory Keepers Medical Discovery Team, University of Minnesota Medical School, Duluth, Minnesota, United States of America.

Julia Kravchenko (J)

Environmental Health Scholars Program, Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, United States of America.

H Kim Lyerly (HK)

Environmental Health Scholars Program, Division of Surgical Sciences, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, United States of America.
Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH